度普利尤单抗对皮肤屏障功能的影响:一项系统综述
本系统综述遵循PRISMA指南,最终纳入6项前瞻性观察性研究、共233名特应性皮炎患者,评估度普利尤单抗对皮肤屏障的无创检测指标影响。度普利尤单抗改善所有研究的临床评分,并降低湿疹皮损及非受累皮肤的经皮水分丢失,部分研究报告增加角质层水合、降低温度并改善神经酰胺组成。
要点
- 度普利尤单抗可降低特应性皮炎患者湿疹皮损及非受累皮肤的经皮水分丢失。
- 约33.6%(2/6)研究报告度普利尤单抗增加湿疹皮损的角质层水合,1项研究报告该参数无变化。
- 度普利尤单抗还可降低皮肤温度并改善神经酰胺组成。
核心结论
- 度普利尤单抗改善特应性皮炎患者的皮肤屏障功能,主要反映为经皮水分丢失值降低。
研究设计与样本
- 遵循PRISMA指南设计的系统综述,文献检索识别73篇参考文献,最终纳入6项前瞻性观察性研究,共233名参与者。
主要发现
- 所有研究均显示度普利尤单抗改善临床评分。
- 皮肤屏障功能参数主要在掌侧前臂测量,经皮水分丢失是所有研究中最常测量的参数。
- 度普利尤单抗降低湿疹皮损及非受累皮肤的经皮水分丢失。
- 约33.6%(2/6)研究报告度普利尤单抗增加湿疹皮损的角质层水合,而1项研究报告该参数无变化。
- 度普利尤单抗还降低皮肤温度并改善神经酰胺组成。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Skin barrier dysfunction plays an important role in atopic dermatitis (AD) aetiopathogenesis. Dupilumab, a drug that inhibits IL-4 and IL-13, is an effective treatment for AD but there is scarce evidence about its impact on epidermal barrier. The objective of this systematic review is to evaluate the influence of dupilumab on skin barrier in patients with AD using non-invasive tools. A systematic review was designed following PRISMA guidelines. The literature search identified 73 references and, finally, only 6 were selected, including a total of 233 participants. All the studies were prospective observational studies. Dupilumab improved clinical scores in all the research. Skin barrier function parameters were mainly measured on the volar forearm. Transepidermal water loss (TEWL) was the parameter most frequently measured, evaluated in all the studies. Dupilumab decreased TEWL on eczematous lesions and non-involved skin. About 33.6% (2/6) studies reported that dupilumab also increased stratum corneum hydration (SCH) on eczematous lesions while one study did not report any changes in this parameter. This drug also decreased temperature and improved ceramide composition. In conclusion, dupilumab improved skin barrier function in AD patients, mainly reflected in a decreased in TEWL values.
引用
- Montero-Vilchez T, Sanabria-de-la-Torre R, Sanchez-Diaz M, et al. The impact of dupilumab on skin barrier function: A systematic review. J Eur Acad Dermatol Venereol. 2023. PMID: 36995919. doi:10.1111/jdv.19081
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。